Search

everythinglearnresearchcommunity

for

Search:↓

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Hedychium spicatum has medicinal properties but needs more research for scientific validation and use.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

In vivo confocal scanning laser microscopy is an effective, non-invasive way to study and measure new hair growth after skin injury in mice.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Juniperus plants contain compounds with potential for developing various medical treatments.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Skin treatment can lower life quality for patients with skin conditions.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Troxerutin helps protect skin cells from oxidative stress and may be good for treating hair loss.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

A mutation in the KRT71 gene causes a hair disorder by disrupting hair follicle structure and texture.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Stress turns hair white by depleting color-giving cells in hair follicles through a specific neurotransmitter related to the body's stress response.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Human hair contains more glycosaminoglycans in children than adults, and these compounds decrease with age, possibly affecting hair thickness.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Gamma-ray exposure can cause long-lasting damage to hair follicles, affecting hair structure and color.